Supernus Pharmaceuticals (NASDAQ:SUPN) Issues Quarterly Earnings Results
Supernus Pharmaceuticals (NASDAQ:SUPN – Get Free Report) released its quarterly earnings results on Monday. The specialty pharmaceutical company reported $0.69 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.44 by $0.25, Briefing.com reports. Supernus Pharmaceuticals had a net margin of 9.16% and a return on equity of 7.94%. The firm had […]
More Stories
Talanx (ETR:TLX) Trading 1.2% Higher – What’s Next?
Shares of Talanx AG (ETR:TLX – Get Free Report) shot up 1.2% on Wednesday . The company traded as high...
Albion Technology & Gen VCT (LON:AATG) Trading Up 2.1% – Should You Buy?
Albion Technology & Gen VCT (LON:AATG – Get Free Report)’s share price rose 2.1% during trading on Wednesday . The...
Acasti Pharma (CVE:ACST) Shares Up 1.8% – Still a Buy?
Acasti Pharma Inc. (CVE:ACST – Get Free Report)’s stock price rose 1.8% on Wednesday . The stock traded as high...
Invesco S&P 500 Equal Weight Energy ETF (NYSEARCA:RYE) Hits New 52-Week High – Still a Buy?
Invesco S&P 500 Equal Weight Energy ETF (NYSEARCA:RYE – Get Free Report)’s stock price hit a new 52-week high on...
Superior Gold (CVE:SGI) Trading 2.6% Higher – Here’s Why
Shares of Superior Gold Inc. (CVE:SGI – Get Free Report) were up 2.6% on Wednesday . The stock traded as...
Uwharrie Capital (OTCMKTS:UWHR) Trading Up 3% – Still a Buy?
Uwharrie Capital Corp (OTCMKTS:UWHR – Get Free Report) shares were up 3% on Wednesday . The stock traded as high...